Eton Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Eton Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $25.94 million for the year ending 2025.

  • Eton Pharmaceuticals, Inc. showed an increase of +73.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Eton Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Eton Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 97.2%.
  • Historical annual values: Fiscal year 2025: $25.94 million | Fiscal year 2024: $14.94 million | Fiscal year 2023: $21.39 million | Fiscal year 2022: $16.31 million | Fiscal year 2021: $14.41 million | Fiscal year 2020: $21.30 million | Fiscal year 2019: $12.07 million | Fiscal year 2018: $26.74 million | Fiscal year 2017: $13.16 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: